Long non-coding RNA MINCR promotes gallbladder cancer progression through stimulating EZH2 expression

Batista, 2013, Long noncoding RNAs: cellular address codes in development and disease, Cell, 152, 1298, 10.1016/j.cell.2013.02.012 Fatica, 2014, Long non-coding RNAs: new players in cell differentiation and development, Nat. Rev. Genet, 15, 7, 10.1038/nrg3606 Lee, 2012, Epigenetic regulation by long noncoding RNAs, Science, 338, 1435, 10.1126/science.1231776 Prensner, 2013, The long noncoding RNA SChLAP1 promotes aggressive prostate cancer and antagonizes the SWI/SNF complex, Nat. Genet, 45, 1392, 10.1038/ng.2771 Yuan, 2014, A long noncoding RNA activated by TGF-beta promotes the invasion-metastasis cascade in hepatocellular carcinoma, Cancer Cell, 25, 666, 10.1016/j.ccr.2014.03.010 Wang, 2015, The long noncoding RNA lncTCF7 promotes self-renewal of human liver cancer stem cells through activation of Wnt signaling, Cell Stem Cell, 16, 413, 10.1016/j.stem.2015.03.003 Geisler, 2013, RNA in unexpected places: long non-coding RNA functions in diverse cellular contexts, Nat. Rev. Mol. Cell Biol, 14, 699, 10.1038/nrm3679 Salmena, 2011, A ceRNA hypothesis: the Rosetta Stone of a hidden RNA language?, Cell, 146, 353, 10.1016/j.cell.2011.07.014 Zheng, 2014, Dicer-microRNA-Myc circuit promotes transcription of hundreds of long noncoding RNAs, Nat. Struct. Mol. Biol, 21, 585, 10.1038/nsmb.2842 Hart, 2014, MYC regulates the non-coding transcriptome, Oncotarget, 5, 12543, 10.18632/oncotarget.3033 Prensner, 2014, The long non-coding RNA PCAT-1 promotes prostate cancer cell proliferation through cMyc, Neoplasia, 16, 900, 10.1016/j.neo.2014.09.001 Hung, 2014, A long noncoding RNA connects c-Myc to tumor metabolism, Proc. Natl. Acad. Sci. U.S.A., 111, 18697, 10.1073/pnas.1415669112 Doose, 2015, MINCR is a MYC-induced lncRNA able to modulate MYC's transcriptional network in Burkitt lymphoma cells, Proc. Natl. Acad. Sci. U.S.A., 112, E5261, 10.1073/pnas.1505753112 Vire, 2006, The Polycomb group protein EZH2 directly controls DNA methylation, Nature, 439, 871, 10.1038/nature04431 Yamaguchi, 2009, Papillary hyperplasia of the gallbladder in pancreaticobiliary maljunction represents a senescence-related lesion induced by lysolecithin, Lab. Invest, 89, 1018, 10.1038/labinvest.2009.65 Yamaguchi, 2010, Histone deacetylase inhibitor (SAHA) and repression of EZH2 synergistically inhibit proliferation of gallbladder carcinoma, Cancer Sci, 101, 355, 10.1111/j.1349-7006.2009.01387.x Liu, 2011, Overexpression of EZH2 and loss of expression of PTEN is associated with invasion, metastasis, and poor progression of gallbladder adenocarcinoma, Pathol. Res. Pract, 207, 472, 10.1016/j.prp.2011.05.010 Pasquinelli, 2012, MicroRNAs and their targets: recognition, regulation and an emerging reciprocal relationship, Nat. Rev. Genet, 13, 271, 10.1038/nrg3162 Chang, 2008, Widespread microRNA repression by Myc contributes to tumorigenesis, Nat. Genet, 40, 43, 10.1038/ng.2007.30 Zeitels, 2014, Tumor suppression by miR-26 overrides potential oncogenic activity in intestinal tumorigenesis, Genes Dev, 28, 2585, 10.1101/gad.250951.114 Ji, 2009, MicroRNA expression, survival, and response to interferon in liver cancer, N. Engl. J. Med, 361, 1437, 10.1056/NEJMoa0901282 Lu, 2011, MiR-26a inhibits cell growth and tumorigenesis of nasopharyngeal carcinoma through repression of EZH2, Cancer Res, 71, 225, 10.1158/0008-5472.CAN-10-1850 Zhang, 2012, MicroRNA-26a promotes cholangiocarcinoma growth by activating beta-catenin, Gastroenterology, 143, 246, 10.1053/j.gastro.2012.03.045 Wang, 2016, Long noncoding RNA H19 contributes to gallbladder cancer cell proliferation by modulated miR-194-5p targeting AKT2, Tumour Biol, 1, 10.1007/s13277-015-4142-3 Wang, 2016, Genome-wide long non-coding RNA analysis identified circulating LncRNAs as novel non-invasive diagnostic biomarkers for gynecological disease, Sci. Rep, 6, 23343, 10.1038/srep23343 Zhang, 2014, NRF2/long noncoding RNA ROR signaling regulates mammary stem cell expansion and protects against estrogen genotoxicity, J. Biol. Chem, 289, 31310, 10.1074/jbc.M114.604868 Ma, 2015, Long non-coding RNA CCAT1 promotes gallbladder cancer development via negative modulation of miRNA-218-5p, Cell Death Dis, 6, e1583, 10.1038/cddis.2014.541 Alajez, 2010, Enhancer of Zeste homolog 2 (EZH2) is overexpressed in recurrent nasopharyngeal carcinoma and is regulated by miR-26a, miR-101, and miR-98, Cell Death Dis, 1, e85, 10.1038/cddis.2010.64 Filipowicz, 2008, Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight?, Nat. Rev. Genet, 9, 102, 10.1038/nrg2290 Schumperli, 2004, The special Sm core structure of the U7 snRNP: far-reaching significance of a small nuclear ribonucleoprotein, Cell. Mol. Life Sci, 61, 2560, 10.1007/s00018-004-4190-0 Benetatos, 2013, Non-coding RNAs and EZH2 interactions in cancer: long and short tales from the transcriptome, Int. J. Cancer, 133, 267, 10.1002/ijc.27859 Tam, 2013, The epigenetics of epithelial-mesenchymal plasticity in cancer, Nat. Med, 19, 1438, 10.1038/nm.3336 Xiong, 2013, Identification and analysis of the regulatory network of Myc and microRNAs from high-throughput experimental data, Comput. Biol. Med, 43, 1252, 10.1016/j.compbiomed.2013.06.002 Jackstadt, 2013, Genome-wide analysis of c-MYC-regulated mRNAs and miRNAs, and c-MYC DNA binding by next-generation sequencing, Methods Mol. Biol, 1012, 145, 10.1007/978-1-62703-429-6_11 Sander, 2008, MYC stimulates EZH2 expression by repression of its negative regulator miR-26a, Blood, 112, 4202, 10.1182/blood-2008-03-147645 Gao, 2011, The role of miR-26 in tumors and normal tissues (Review), Oncol. Lett, 2, 1019, 10.3892/ol.2011.413 Fu, 2014, miR-26a enhances miRNA biogenesis by targeting Lin28B and Zcchc11 to suppress tumor growth and metastasis, Oncogene, 33, 4296, 10.1038/onc.2013.385 Liu, 1822, MiR-26a enhances metastasis potential of lung cancer cells via AKT pathway by targeting PTEN, Biochim. Biophys. Acta, 2012, 1692 Huse, 2009, The PTEN-regulating microRNA miR-26a is amplified in high-grade glioma and facilitates gliomagenesis in vivo, Genes Dev, 23, 1327, 10.1101/gad.1777409 Zhu, 2012, MicroRNA-26a/b and their host genes cooperate to inhibit the G1/S transition by activating the pRb protein, Nucleic Acids Res, 40, 4615, 10.1093/nar/gkr1278 Kota, 2009, Therapeutic microRNA delivery suppresses tumorigenesis in a murine liver cancer model, Cell, 137, 1005, 10.1016/j.cell.2009.04.021 Lin, 2013, miR-26a inhibits proliferation and motility in bladder cancer by targeting HMGA1, FEBS Lett, 587, 2467, 10.1016/j.febslet.2013.06.021 Chen, 2011, Tumor-specific expression of microRNA-26a suppresses human hepatocellular carcinoma growth via cyclin-dependent and -independent pathways, Mol. Ther, 19, 1521, 10.1038/mt.2011.64 Ciarapica, 2009, Deregulated expression of miR-26a and Ezh2 in rhabdomyosarcoma, Cell Cycle, 8, 172, 10.4161/cc.8.1.7292 Zhang, 2011, Pathologically decreased miR-26a antagonizes apoptosis and facilitates carcinogenesis by targeting MTDH and EZH2 in breast cancer, Carcinogenesis, 32, 2, 10.1093/carcin/bgq209 Borno, 2012, Genome-wide DNA methylation events in TMPRSS2-ERG fusion-negative prostate cancers implicate an EZH2-dependent mechanism with miR-26a hypermethylation, Cancer Discov, 2, 1024, 10.1158/2159-8290.CD-12-0041 Reuland, 2013, MicroRNA-26a is strongly downregulated in melanoma and induces cell death through repression of silencer of death domains (SODD), J. Invest. Dermatol, 133, 1286, 10.1038/jid.2012.400 Salvatori, 2011, Critical role of c-Myc in acute myeloid leukemia involving direct regulation of miR-26a and histone methyltransferase EZH2, Genes Cancer, 2, 585, 10.1177/1947601911416357 Yang, 2013, MicroRNA-26a suppresses tumor growth and metastasis of human hepatocellular carcinoma by targeting interleukin-6-Stat3 pathway, Hepatology, 58, 158, 10.1002/hep.26305 Dang, 2012, MicroRNA-26a regulates tumorigenic properties of EZH2 in human lung carcinoma cells, Cancer Genet, 205, 113, 10.1016/j.cancergen.2012.01.002 Koh, 2011, Myc enforces overexpression of EZH2 in early prostatic neoplasia via transcriptional and post-transcriptional mechanisms, Oncotarget, 2, 669, 10.18632/oncotarget.327 Zhao, 2013, Disruption of the MYC-miRNA-EZH2 loop to suppress aggressive B-cell lymphoma survival and clonogenicity, Leukemia, 27, 2341, 10.1038/leu.2013.94